About Hyperphenylalaninemia due to DNAJC12 deficiency
Hyperphenylalaninemia due to DNAJC12 deficiency is a rare disease catalogued by Orphanet (ORPHA:508523). It is associated with the DNAJC12 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Hyperphenylalaninemia due to DNAJC12 deficiency trials.
Search ClinicalTrials.gov for "Hyperphenylalaninemia due to DNAJC12 deficiency" or filter by Orphanet code ORPHA:508523 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Hyperphenylalaninemia due to DNAJC12 deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Hyperphenylalaninemia due to DNAJC12 deficiency. Updated daily.